All the news Showing 10 of 330 articles from: Access to medicines & diagnosticsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Louisiana picks drug company for hepatitis C treatment plan San Francisco Chronicle / 27 March 2019 Interview With Charles Gore, Medicines Patent Pool Executive Director Intellectual Property Watch / 24 March 2019 Countries Use Novel Strategies to Tackle Price of HCV Drugs Medscape / 15 February 2019 Malaysia Still Under Pressure To Make Hepatitis C Medicine More Expensive Intellectual Property Watch / 15 February 2019 Tackling HIV and hepatitis C in Europe: towards minimum standards Gus Cairns / 11 February 2019 Despite the huge disparities in care that were highlighted, last week's Standard of Care for HIV and Coinfections in Europe meeting in Bucharest featured discussions that could form the basis of a European-wide ... Generic DAAs achieve excellent cure rates in Egypt matching those of branded drugs at a fraction of the cost Michael Carter / 01 February 2019 Generic direct-acting antivirals (DAAs) are just as effective and safe as their branded equivalents for the treatment of chronic hepatitis C virus (HCV) infection, according to Egyptian research published in Liver International. Generics achieved ... Barriers to HCV treatment access from the drug user's point of view: stigma, complex lives and damaged veins Keith Alcorn / 16 January 2019 Despite access to hepatitis C treatment, many people who inject drugs still perceive numerous barriers to starting treatment, including the attitudes of healthcare workers, the difficulty of juggling treatment with competing demands, a ... Hepatitis C Drugs in 2019: Price Drops and Generic Pipeline in Place Hepatitis Central / 16 January 2019 Lancet commission sets agenda for the elimination of viral hepatitis Keith Alcorn / 10 January 2019 Viral hepatitis leads to around 1.3 million deaths a year, approximately 257 million people are living with hepatitis B virus (HBV) and 71 million with hepatitis C virus (HCV). Viral hepatitis ... Appeal lodged against decision to uphold Gilead’s patent on hepatitis C drug MSF / 05 December 2018 ← Prev12345...33Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Email bulletin archive